Pfizer ' s ELREXFIO ™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma

Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Health | Myeloma | Pfizer